SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

news from cphi

CDMO strategic deals 'the new standard,' say Catalent and DPx, but big and small pharma demands differ

Strategic relationships with contract manufacturers are becoming the standard, but big and small pharma demands differ considerably according to the two largest CDMOs, DPx and Catalent.

News from cphi

Big Pharmas and API suppliers eyeing Brazilian Government deals says EMS

Government contracts guaranteeing market share in Brazil are starting to attract innovators like Roche, Novartis and Sanofi and may see API suppliers get long-term work according to a spokesman for Sao Bernardo do Campo-based drugmaker, EMS.

Novartis calls on Covance to help with Big Data

Covance’s collection of drug development data is set to get bigger though a collaboration with Swiss drugmaker Novartis.

MedImmune teams with UK academics on neurodegenerative disease research

MedImmune’s neurodegenerative disease partnership with the University of Cambridge is about working with “great scientists with great brains” according to a spokeswoman for parent company, AstraZeneca.

ISI Group gets behind Quintiles while downgrading Pfizer's strategic partners ICON and Parexel

The investment bank ISI Group has selected Quintiles as its preferred CRO while concurrently downgrading Pfizer’s strategic partners Parexel and ICON.

Spotlight

Public CROs are sign of booming market, not PE apathy say experts
News focus

Public CROs are sign of booming market, not PE apathy say financial advisors

Experts have predicted more CROs will go public as Private Equity looks to get a return on...

Biologics trials: the ‘stretched’ global supply chain

Biologics trials: the ‘stretched’ global supply chain

The high cost and complexity of producing biopharmaceuticals for clinical trials limits supplies and makes effective logistics...

Charles River to lay off up to 30 employees following NCI contract end

Charles River to lay off up to 30 employees following NCI contract termination

Early phase CRO (contract research organization) Charles River Laboratories will lay off between 26 and 30 employees...

Pharma firms ‘saving billions’ in research – by giving away their tech

Pharma firms ‘saving billions’ in research – by giving away their tech

Pharma’s biggest players have donated more than $102m ($78m) of technology in a project to transform data...

CMO Kentucky Bioprocessing grows Ebola mAb from tobacco

CMO Kentucky Bioprocessing grows Ebola mAb from tobacco

ZMapp, the experimental Ebola therapy given to a handful of infected patients in West Africa, is being...

CRO Crown: Advancing in vitro models could benefit preclinical world

Crown Bio: New in vitro technology could revolutionise drug discovery

Increasing the predictivity of in vitro systems could cut the costs of drug development and shift preclinical...